TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,955 | +11.3% | 2,906 | +13.0% | 0.00% | – |
| Q2 2023 | $40,406 | -2.6% | 2,572 | +2.1% | 0.00% | – |
| Q1 2023 | $41,496 | -31.1% | 2,518 | -34.7% | 0.00% | -100.0% |
| Q4 2022 | $60,201 | +62.7% | 3,859 | +36.1% | 0.00% | – |
| Q3 2022 | $37,000 | -7.5% | 2,836 | 0.0% | 0.00% | – |
| Q2 2022 | $40,000 | -32.2% | 2,836 | -31.3% | 0.00% | -100.0% |
| Q1 2022 | $59,000 | +51.3% | 4,126 | +45.5% | 0.00% | – |
| Q4 2021 | $39,000 | -15.2% | 2,836 | +0.0% | 0.00% | – |
| Q3 2021 | $46,000 | -16.4% | 2,835 | -13.5% | 0.00% | -100.0% |
| Q2 2021 | $55,000 | +19.6% | 3,276 | +30.2% | 0.00% | 0.0% |
| Q1 2021 | $46,000 | 0.0% | 2,517 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $46,000 | +2.2% | 2,517 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $45,000 | 0.0% | 2,517 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $45,000 | -48.9% | 2,517 | -56.4% | 0.00% | -50.0% |
| Q1 2020 | $88,000 | -30.2% | 5,772 | -10.2% | 0.00% | 0.0% |
| Q4 2019 | $126,000 | +93.8% | 6,427 | +68.1% | 0.00% | +100.0% |
| Q3 2019 | $65,000 | -42.0% | 3,824 | -39.4% | 0.00% | -50.0% |
| Q2 2019 | $112,000 | -16.4% | 6,307 | -4.3% | 0.00% | 0.0% |
| Q1 2019 | $134,000 | – | 6,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |